Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference75 articles.
1. de Biase S, Gigli GL, Valente M, Merlino G. Lacosamide for the treatment of epilepsy. Expert Opin Drug Metab Toxicol. 2014;10:459–68.
2. Beydoun A, D’Souza J, Hebert D, Doty P. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Expert Rev Neurother. 2009;9:33–42.
3. UCB Pharma. Vimpat® (lacaosmide): EMA summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000863/WC500050338.pdf . Accessed 4 July 2014.
4. Cawello W, Stockis A, Andreas JO, Dimova S. Advances in epilepsy treatment: lacosamide pharmacokinetic profile. Ann N Y Acad Sci. 2014;1329:18–32.
5. Fountain NB. Choosing among antiepileptic drugs. Continuum (Minneap Minn). 2010;16(3 Epilepsy):121–35.
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献